The Affordable Care Act (ACA) requires that, beginning in 2012, manufacturers of specified drugs, medical devices, and biologicals participating in U.S. federal health care programs must begin tracking any transfers of value or payments of $10 or more (as indexed by Consumer Price Index) to physicians and teaching hospitals. These reports must be submitted to the Secretary of the Department of Health and Human Services on an annual basis. The majority of the information contained in the reports will be available on a public, searchable website in 2013. In addition, the ACA mandates that manufacturers and group purchasing organizations must report ownership interests held by physicians and their close family members.
CMS Physician Sunshine Rule